[1]
Dalle Carbonare, L., Bertoldo, F. and Lo Cascio, V. 1. Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project. Reumatismo. 61, 1 (1), 54-64. DOI:https://doi.org/10.4081/reumatismo.2009.54.